Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CERo Therapeutics Holdings ( (CERO) ) just unveiled an update.
On October 29, 2025, CERo Therapeutics Holdings, Inc., a Delaware-based company, was notified by a Nasdaq Hearing Panel that its securities would be delisted from the Nasdaq Stock Market, with trading suspended effective at the opening of trading on October 31, 2025. The company appealed this decision to the Nasdaq Listing and Hearing Review Council, but on January 29, 2026, the Council affirmed the Panel’s decision, confirming the delisting of the company’s securities from Nasdaq and signaling a significant setback for its public market presence and liquidity for shareholders.
The most recent analyst rating on (CERO) stock is a Hold with a $0.10 price target. To see the full list of analyst forecasts on CERo Therapeutics Holdings stock, see the CERO Stock Forecast page.
More about CERo Therapeutics Holdings
Average Trading Volume: 626,819
Technical Sentiment Signal: Sell
Current Market Cap: $1M
For a thorough assessment of CERO stock, go to TipRanks’ Stock Analysis page.